Cannabinor

Uses your system voice; voice and rate in settings.

Snapshot

≈ 1 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

Cannabinor (PRS-211,375) is a drug which acts as a potent and selective cannabinoid CB 2 receptor agonist. It is classed as a "nonclassical" cannabinoid with a chemical structure similar to that of cannabidiol. It has a CB 2 affinity of 17.4 nM vs 5,585 nM at CB 1 , giving it over 300× selectivity for CB 2 . It showed analgesic effects in animal studies especially in models of neuropathic pain, but failed in Phase IIb human clinical trials due to lack of efficacy.

Cannabinor (PRS-211,375) is a drug which acts as a potent and selective cannabinoid CB 2 receptor agonist. It is classed as a "nonclassical" cannabinoid with a chemical structure similar to that of cannabidiol. It has a CB 2 affinity of 17.4 nM vs 5,585 nM at CB 1 , giving it over 300× selectivity for CB 2 . It showed analgesic effects in animal studies especially in models of neuropathic pain, but failed in Phase IIb human clinical trials due to lack of efficacy.

See also

Cannabicyclohexanol O-1871

Text derived from https://en.wikipedia.org/w/index.php?oldid=1330136523 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

No external citation was extracted for this revision. That is a statement about the source, not a claim that none exists.